In vivo deletion analysis of the herpes simplex virus type 1 latency-associated transcript promoter - PubMed (original) (raw)

In vivo deletion analysis of the herpes simplex virus type 1 latency-associated transcript promoter

A T Dobson et al. J Virol. 1995 Apr.

Abstract

During herpes simplex virus latency, transcripts accumulate from a single transcription unit of the viral genome. The promoter for these latency-associated transcripts (LAT) has been located, and a number of studies have documented the specific regions of this promoter which are important in transient assays of neuronal cells in culture. To examine the regulation of this promoter from the viral genome, both in vitro and in vivo, a series of seven promoter deletion viruses which drive the expression of the reporter gene beta-galactosidase was constructed. Rabbit skin cells were infected in cell culture with viruses bearing each promoter mutation, and the LAT promoter activity was compared with that obtained by infecting two neuronal cell lines, ND7 cells and C1300 neuroblastoma cells. Mouse dorsal root ganglia were also infected with these recombinant viruses by footpad inoculations, and beta-galactosidase activity was measured. Infected neuronal cells lines and dorsal root ganglia exhibit much more LAT promoter activity than infected rabbit skin cells, suggesting that the region upstream of -250 may contain one or several neuronal specific DNA-binding sites. However, a comparison of LAT promoter activities within the deletion series revealed many differences between neurons of the dorsal root ganglia infected in vivo and the two neuronal cell lines infected in vitro. These results suggest that neurons may vary extensively in the quantity or kind of transcription factors they contain.

PubMed Disclaimer

Cited by

A 16 bp upstream sequence from the rat tyrosine hydroxylase promoter supports long-term expression from a neurofilament promoter, in a helper virus-free HSV-1 vector system.
Zhang GR, Zhao H, Li X, Awasthi S, Geller AI. Zhang GR, et al. Brain Res. 2011 Sep 30;1415:109-18. doi: 10.1016/j.brainres.2011.07.061. Epub 2011 Aug 6. Brain Res. 2011. PMID: 21885041 Free PMC article.
Towards an understanding of the herpes simplex virus type 1 latency-reactivation cycle.
Perng GC, Jones C. Perng GC, et al. Interdiscip Perspect Infect Dis. 2010;2010:262415. doi: 10.1155/2010/262415. Epub 2010 Feb 15. Interdiscip Perspect Infect Dis. 2010. PMID: 20169002 Free PMC article.
De novo synthesis of VP16 coordinates the exit from HSV latency in vivo.
Thompson RL, Preston CM, Sawtell NM. Thompson RL, et al. PLoS Pathog. 2009 Mar;5(3):e1000352. doi: 10.1371/journal.ppat.1000352. Epub 2009 Mar 27. PLoS Pathog. 2009. PMID: 19325890 Free PMC article.
Tissue-specific splicing of the herpes simplex virus type 1 latency-associated transcript (LAT) intron in LAT transgenic mice.
Gussow AM, Giordani NV, Tran RK, Imai Y, Kwiatkowski DL, Rall GF, Margolis TP, Bloom DC. Gussow AM, et al. J Virol. 2006 Oct;80(19):9414-23. doi: 10.1128/JVI.00530-06. J Virol. 2006. PMID: 16973547 Free PMC article.
Prediction and identification of herpes simplex virus 1-encoded microRNAs.
Cui C, Griffiths A, Li G, Silva LM, Kramer MF, Gaasterland T, Wang XJ, Coen DM. Cui C, et al. J Virol. 2006 Jun;80(11):5499-508. doi: 10.1128/JVI.00200-06. J Virol. 2006. PMID: 16699030 Free PMC article.

References

1. J Gen Virol. 1989 Aug;70 ( Pt 8):2163-9 - PubMed
1. J Virol. 1989 Sep;63(9):3844-51 - PubMed
1. J Gen Virol. 1990 Apr;71 ( Pt 4):953-7 - PubMed
1. J Virol. 1990 Jul;64(7):3269-79 - PubMed
1. J Virol. 1990 Oct;64(10):5019-28 - PubMed

In vivo deletion analysis of the herpes simplex virus type 1 latency-associated transcript promoter - PubMed (original) (raw)